SGLT-2 inhibitors improve glycemic control by reducing blood glucose levels and enhancing insulin sensitivity, thereby mitigating the detrimental effects of hyperglycemia on neuronal cells. This evidence concerns the gene SLC5A2 and Hyperglycemia.